^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Cervical Cancer |
| Drug: | carboplatin (Tubulin polymerization promoter) + etoposide oral (Topoisomerase II inhibitor, DNA inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Cervical cancer: Systemic therapy for cervical cancer…small cell NECC…neoadjuvant therapy, adjuvant therapy, recurrent or metastatic disease…first-line therapy…preferred regimens…carboplatin/etoposide
